<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>创新药 on 没用知识库</title><link>https://blog.alansun.host/tags/%E5%88%9B%E6%96%B0%E8%8D%AF/</link><description>Recent content in 创新药 on 没用知识库</description><generator>Hugo -- gohugo.io</generator><language>zh-cn</language><managingEditor>alansundy@gmail.com (羊羊羊)</managingEditor><webMaster>alansundy@gmail.com (羊羊羊)</webMaster><copyright>© 2026 羊羊羊</copyright><lastBuildDate>Tue, 21 Jul 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://blog.alansun.host/tags/%E5%88%9B%E6%96%B0%E8%8D%AF/index.xml" rel="self" type="application/rss+xml"/><item><title>CXO 医药外包深度研究：创新药时代的“卖水人”与产业链景气传导</title><link>https://blog.alansun.host/posts/20260721_cxo%E5%8C%BB%E8%8D%AF%E5%A4%96%E5%8C%85/</link><pubDate>Tue, 21 Jul 2026 00:00:00 +0000</pubDate><author>alansundy@gmail.com (羊羊羊)</author><guid>https://blog.alansun.host/posts/20260721_cxo%E5%8C%BB%E8%8D%AF%E5%A4%96%E5%8C%85/</guid><description>沿着“上游科研试剂设备 → 临床前/临床 CRO → 小分子、多肽与 ADC 药物 CDMO”的价值链条，剖析全球创新药研发复苏背景下的中国 CXO 产业壁垒与景气传导顺序。</description><media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://blog.alansun.host/posts/20260721_cxo%E5%8C%BB%E8%8D%AF%E5%A4%96%E5%8C%85/featured.jpg"/></item></channel></rss>